Lobe Sciences Ltd. LOBEF
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 48.43% | -97.76% | 53.59% | -101.97% | -42.50% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.52% | 88.76% | -220.51% | 1,100.99% | -125.72% |
| Change in Net Operating Assets | 213.29% | -126.28% | -25.99% | 86.37% | 276.80% |
| Cash from Operations | 65.63% | -261.27% | -42.70% | -0.10% | -13.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.56% | -539.86% | 138.54% | -- | -- |
| Cash from Investing | 106.56% | -539.86% | 138.54% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -48.40% | -61.04% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.99% | 3,147.41% |
| Cash from Financing | -- | -100.00% | 773.17% | -99.93% | 1,875.64% |
| Foreign Exchange rate Adjustments | 22.73% | -37.14% | 113.94% | -230.05% | 143.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.82% | -3,735.13% | 106.39% | -127.28% | 627,877.78% |